Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NDORMS, with the Botnar Research Institute and Kennedy Institute of Rheumatology, has been designated a EULAR Centre of Excellence in Rheumatology 2015-2020, in recognition of our continued high-quality research publications in rheumatology.

EULAR, the European League Against Rheumatism, represents patients, health professionals and scientific societies of rheumatology of all European nations. It aims to reduce the burden of rheumatic diseases on the individual and society and to improve the treatment, prevention and rehabilitation of musculoskeletal diseases.

Its Centres of Excellence are top rheumatology research units in Europe aiming to develop a group of first-class research centres for active researchers and enable exchange of fellows and research projects.

NDORMS is one of the largest and most dynamic multidisciplinary academic rheumatology research centres in the world, with over 50 dedicated researchers focusing on rheumatic conditions.

We have one of the largest and broadest groupings of translational rheumatology research in the world; covering inflammatory, degenerative and congenital diseases of the musculoskeletal system. Scientific approaches include direct patient-focused research, epidemiology, and basic mechanistic research in immunology, genetics, bone, matrix and cartilage biology.

Professor Paul Bowness, who led on the department's application, assisted by Professor Richard Williams from the Kennedy Institute said: "We are delighted with this award and the recognition it brings to NDORMS for its research into diverse rheumatic conditions and important rheumatology research is for the lives of millions of people around the world. This supports our mission to develop and deliver excellent clinical and basic research and foster collaborations with other Centres of Excellence."

Similar stories

The new Botnar strategy is announced

After a year as the Director of the Botnar Institute for Musculoskeletal Sciences, Professor Jonathan Rees announces a new structure and strategy that will further enhance research and treatment of bone, joint and musculoskeletal conditions.

Sara Khalid named Associate Professor at NDORMS

The University of Oxford has awarded the title of Associate Professor to Dr Sara Khalid as part of its recognition of excellence awards.

New global health grant to improve outcomes for patients with hip fracture

Hip fracture patients in Low- and Middle-Income Countries (LMIC) in Asia are set to benefit from a new study that aims to bring best practice programmes to improve quality of life for patients and reduce healthcare costs.

NDORMS welcomes great-granddaughter of former Head of Department

Julia Strubell, great-granddaughter of Professor Josep Trueta, visited NDORMS to find out about his time here and to share her own work with staff and students.

Botnar researchers awarded Fellowships

Arani Vivekanantham has been awarded an NIHR Doctoral Fellowship and a Versus Arthritis Clinical Research Fellowship, and Rachel Kuo was awarded an NIHR Doctoral Research Fellowship.

Better diagnosis and treatment of autoimmune diseases moves a step closer

A study published in Nature outlines a way to find the crucial peptides (protein fragments) that drive autoimmunity, as well as the immune cells that respond to them.